Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health, Inc. Chief Accounting Officer Nicole Maggio reported a tax-withholding disposition of company stock. On February 24, 2026, she used 975 shares of common stock, valued at $33.815 per share, to satisfy tax obligations. After this transaction, she directly owned 28,489 shares of Option Care Health common stock.
Option Care Health reported proposed sales of Common Stock on a Form 144. The filing lists multiple sale entries, including 750 shares on 08/20/2025 and 2,967 shares on 05/20/2025, with other award-related share amounts shown for dates in 2022–2025.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two tax-related share dispositions tied to equity compensation. On February 22, he disposed of 12,212 common shares at $35.69 per share to satisfy tax obligations. On February 20, he similarly disposed of 1,187 shares at $35.69 per share for tax withholding. These transactions are coded as tax-withholding events rather than open-market sales, and he continues to hold a meaningful number of shares directly.
Option Care Health, Inc. Chief Growth Officer Christopher L. Grashoff reported two tax-related share dispositions of company common stock. On February 20, 1,948 shares were disposed of at $35.69 per share to cover tax obligations, followed by 538 shares at the same price on February 22. After these tax-withholding dispositions, he directly owns 46,072 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Accounting Officer Nicole Maggio reported two tax-related share dispositions under a compensation plan. On February 20 and 22, she transferred a total of 991 shares of common stock at $35.69 per share to satisfy tax withholding obligations, a non-open-market transaction type coded as "F." After these transactions, she directly owned 29,464 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported two tax-related share dispositions under an equity compensation arrangement. On February 22, 2026, 24,029 shares of common stock were delivered at $35.69 per share to cover taxes, leaving 174,194 shares directly held. On February 20, 2026, 4,015 shares were similarly withheld at $35.69 per share to satisfy tax obligations, after which 198,223 shares were reported as directly owned.
Option Care Health CEO John Charles Rademacher reported a mix of share acquisitions and tax-related dispositions. On February 21, 2026, he exercised 11,087 Restricted Stock Units, each converting into one share of common stock at a stated price of $0.0000 per share.
To cover tax obligations, he reported multiple F-code tax-withholding dispositions of common stock on February 20–22, 2026 at $35.69 per share. After these transactions, his direct ownership stood at 693,702 shares of common stock.
Option Care Health, Inc. reported insider transactions by its General Counsel and Corporate Secretary, Collin Smyser. On February 22, 2026, Smyser disposed of 15,433 shares of common stock at $35.69 per share, and on February 20, 2026, disposed of another 2,012 shares at the same price. Both transactions were coded “F,” meaning shares were surrendered to satisfy tax obligations rather than sold in open-market trades. After these transactions, Smyser held 76,770 shares directly, plus an additional 2,500 shares held indirectly through a revocable trust.
Option Care Health, Inc. is the largest independent U.S. provider of home and alternate-site infusion services, operating 196 locations in 43 states and a team of more than 5,000 clinicians. It runs 87 full-service pharmacies and 109 stand‑alone ambulatory infusion suites to treat complex and chronic conditions ranging from infections to neurological and inflammatory disorders.
The business is highly dependent on third‑party payers; for 2025, 88% of revenue came from managed care and other nongovernmental payers and 12% from direct government programs like Medicare and Medicaid. Its largest payer contributed 14% of revenue, and about 68% of drug and supply purchases came from four vendors, creating concentration risk.
The company discloses $1,176.3 million of debt as of December 31, 2025, split between a $676.3 million first‑lien term loan and $500.0 million of 4.375% senior notes due 2029. It notes federal reimbursement pressure, including Medicare sequestration and a CMS‑negotiated 66% price cut effective January 2026 for one portfolio therapy under the Inflation Reduction Act, as potential headwinds. As of June 30, 2025, non‑affiliate equity value was about $5.27 billion, with 156,447,972 common shares outstanding as of February 19, 2026, and a share repurchase authorization increased to $1 billion in January 2026.
Option Care Health reported solid fourth quarter and full-year 2025 results with continued growth and significant shareholder returns. Fourth quarter net revenue reached $1,465.4 million, up 8.8%, while net income was $58.5 million, down 2.7%. GAAP diluted EPS rose 5.7% to $0.37, and Adjusted EBITDA increased 3.7% to $126.0 million. The company repurchased $95 million of stock in the quarter.
For full year 2025, net revenue grew 13.0% to $5,649.5 million, with net income of $207.6 million, down 2.0%. GAAP diluted EPS increased 3.3% to $1.27, and Adjusted EBITDA rose 6.2% to $471.3 million. Adjusted diluted EPS was $1.72, up 8.9%, and operating cash flow was $258.4 million. The company repurchased $307 million of stock during the year.
Looking to 2026, Option Care Health expects net revenue of $5.8 billion to $6.0 billion, Adjusted EBITDA of $480 million to $505 million, Adjusted diluted EPS of $1.82 to $1.92, and operating cash flow of at least $340 million, signaling confidence in continued growth.